Where Will Moderna Be in 10 Years?
Moderna (NASDAQ: MRNA) has accomplished a lot in only about 18 months. The biotech company has brought its first product to market -- and that product is the blockbuster coronavirus vaccine. So Moderna went from zero product revenue to billions in revenue and profit in a very short period of time. The company also saw its market value climb to as much as $195 billion from $6 billion.
After such a whirlwind of activity, you may now be wondering what's ahead for the company down the road. Some investors worry that Moderna's big moment may have been vaccinating the masses during the pandemic -- and business may go downhill from there. But Moderna has been working for years to ensure it won't be a one-hit wonder in the world of biotech. Let's take a look at where Moderna may be a decade from now.
Image source: Getty Images.
Source Fool.com
